In HCC, PYCR1 drives tumor growth and metastasis by upregulating IRS1; the protein and mRNA levels of PYCR1 and IRS1 (detected by IHC and qPCR, respectively) can serve as a potential diagnostic combination, but their clinical application still requires large-scale trials to verify their specificity and sensitivity. Here, PYCR1 is linked to neoplasm.